Get started
Author

Lianne S.M. Boesten

Observed names: Erik Boersma, L BOESTEN, L S M Boesten, L.S.M. Boesten, Lianne Boesten, Lianne S M Boesten, Lianne S M. Boesten, Lianne S. M. Boesten, Lianne SM Boesten, Lianne Simone Mirjam Boesten, Lianne S. Boesten
Observed institutions: Netherlands Organisation for Applied Scientific Research, University of Antwerp, Cornell University, Leiden University Medical Center, University Medical Center Freiburg, Medisch Centrum Leeuwarden, University Medical Center Utrecht, Sanquin, Ikazia Ziekenhuis, IJsselland Ziekenhuis, The University of Texas Southwestern Medical Center
ORCID: 0000-0001-9505-3516
Observed ORCIDs: 0000-0001-9505-3516, 0000-0002-6717-9565
OpenAlex ID: A5069314241
Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice
2001 · Bart J.M. van Vlijmen, Gery Gerritsen, et al. · Circulation Research · 175
Tumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice
2005 · L BOESTEN, A ZADELAAR, et al. · Cardiovascular Research · 119
Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum
2012 · Marcel J.W. Janssen, Jos P.M. Wielders, et al. · Steroids · 84
Tumor necrosis factor‐α plays an important role in restenosis development
2005 · Pascalle S. Monraats, Nuno M. M. Pires, et al. · The FASEB Journal · 81
Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death
2006 · L S M Boesten, S M Zadelaar, et al. · Cell Death and Differentiation · 71
PDF
Macrophage Low-Density Lipoprotein Receptor-Related Protein Deficiency Enhances Atherosclerosis in ApoE/LDLR Double Knockout Mice
2006 · L. Hu, L.S.M. Boesten, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 64
Dual PPARα/γ Agonist Tesaglitazar Reduces Atherosclerosis in Insulin-Resistant and Hypercholesterolemic ApoE*3Leiden Mice
2006 · A. Susanne M. Zadelaar, Lianne S.M. Boesten, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 47
PDF
Hepatic low-density lipoprotein receptor–related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
2004 · Sonia M. S. Espirito Santo, Nuno M. M. Pires, et al. · Blood · 45
Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study
2008 · Bart W.J. Hellebrekers, Trudy C.M. Trimbos-Kemper, et al. · Fertility and Sterility · 44
Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice
2009 · Lianne S.M. Boesten, A. Susanne M. Zadelaar, et al. · Atherosclerosis · 36
Comparison of ex vivo stability of copeptin and vasopressin
2016 · Judith E. Heida, Lianne S.M. Boesten, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 35
Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE‐deficient mice
2006 · Lianne S. M. Boesten, A. Susanne M. Zadelaar, et al. · The FASEB Journal · 34
Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment
2017 · Debbie Zittema, Niek F. Casteleijn, et al. · PLoS ONE · 33
PDF
The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels
2017 · Esmée M. Ettema, Judith Heida, et al. · Kidney International Reports · 32
PDF
Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries
2005 · N PIRES, A SCHEPERS, et al. · Cardiovascular Research · 25
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
2021 · Martine J Wellens, Charlotte E Vollenbrock, et al. · BMJ Open Diabetes Research & Care · 19
PDF
Fasting and meal‐stimulated serum C‐peptide in long‐standing type 1 diabetes mellitus
2022 · Charlotte E. Vollenbrock, Dick Mul, et al. · Diabetic Medicine · 17
PDF
Impact of Thyroglobulin and Thyroglobulin Antibody Assay Performance on the Differential Classification of DTC Patients
2021 · Lise Schoonen, Marjolein Neele, et al. · Journal of the Endocrine Society · 15
PDF
Misleading FT4 measurement: Assay-dependent antibody interference
2016 · Ingrid Revet, Lianne SM Boesten, et al. · Biochemia Medica · 14
PDF
How low is really low? Comparison of two C‐peptide assays to establish residual C‐peptide production in type 1 diabetes
2022 · Kitty de Leur, Charlotte Vollenbrock, et al. · Diabetic Medicine · 11
PDF
Local Cre-Mediated Gene Recombination in Vascular Smooth Muscle Cells in Mice
2006 · Susanne M. Zadelaar, Lianne S. M. Boesten, et al. · Transgenic Research · 10
Impact of the Choice of IGF-I Assay and Normative Dataset on the Diagnosis and Treatment of Growth Hormone Deficiency in Children
2018 · Maarten A.C. Broeren, Johannes G. Krabbe, et al. · Hormone Research in Paediatrics · 9
[Porphyria cutanea tarda: the benefit of additional diagnostics].
2016 · Allard R J V Vossen, Lianne S M Boesten, et al. · Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank · 5
A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements
2011 · Arjan Albersen, Evelien Kemper-Proper, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 5
Cohort profile: the ‘Biomarkers of heterogeneity in type 1 diabetes’ study—a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands
2024 · Dick Mul, Rita D.M. Varkevisser, et al. · BMJ Open · 4
Works count: 35
Citation count: 1,035
H-index: 17
I10-index: 21
Year
Topic
Type